Jeffrey E. Gershenwald
The University of Texas MD Anderson Cancer Center · 703 works · 60,461 citations · h-index 102
Top works
- Final Version of 2009 AJCC Melanoma Staging and Classification
- Final Version of the American Joint Committee on Cancer Staging System for Cutaneous Melanoma
- Prognostic Factors Analysis of 17,600 Melanoma Patients: Validation of the American Joint Committee on Cancer Melanoma Staging System
- A Landscape of Driver Mutations in Melanoma
- Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients
- Multi-Institutional Melanoma Lymphatic Mapping Experience: The Prognostic Value of Sentinel Lymph Node Status in 612 Stage I or II Melanoma Patients
- Melanoma staging: Evidence‐based changes in the American Joint Committee on Cancer eighth edition cancer staging manual
- Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma
- American Joint Committee on Cancer acceptance criteria for inclusion of risk models for individualized prognosis in the practice of precision medicine
- Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma.
- B cells and tertiary lymphoid structures promote immunotherapy response
- Exome sequencing identifies GRIN2A as frequently mutated in melanoma
- NRAS mutation status is an independent prognostic factor in metastatic melanoma
- A new American Joint Committee on Cancer staging system for cutaneous melanoma
- Loss of PTEN Promotes Resistance to T Cell–Mediated Immunotherapy
- Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade
- Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma
- Multivariate Analysis of Prognostic Factors Among 2,313 Patients With Stage III Melanoma: Comparison of Nodal Micrometastases Versus Macrometastases
- Ethnic Differences Among Patients With Cutaneous Melanoma
- Interleukin 1 receptor blockade attenuates the host inflammatory response.